̘_Xg2004

  1. Haigh JJ, Ema M, Haigh K, Gertsenstein M, Greer PA, Rossant J, Nagy A, Wagner EF. Activated Fps/Fes partially rescues the in vivo developmental potential of Flk1 deficient vascular progenitor cells. Blood. 103,912-920, 2004.
  2. Yamada Y, Itano N, Narimatsu H, Kudo T, Morozumi K, Hirohashi S, Ochiai A, Ueda M, Kimata K. Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer.Clin Exp Metastasis. 21, 57-63, 2004.
  3. Yanagita M, Oka M, Watabe T, Iguchi H, Niida A, Takahashi S, Akiyama T, Miyazono K, Yanagisawa M, Sakurai T. USAG-1: A bone morphogenetic protein (BMP) antagonist abundantly expressed in the kidney. Biochem Bipphys Res Commun. 316,490-500, 2004.
  4. Nakatani K, Fujii H, Hasegawa H, Terada M, Arita N, Ito MR, Ono M, Takahashi S, Saiga K, Yoshimoto S, Iwano M, Shiiki H, Saito Y, Nose M. Endothelial adhesion molecules in glomerular lesions: Association with their severity and diversity in lupus models. Kidney Int. 65, 1290-1300, 2004.
  5. Morito N, Yoh K, Hirayama A, Itoh K, Nose M, Koyama A, Yamamoto M, Takahashi S. Nrf2-deficiency improves autoimmune nephritis caused by the fas mutation lpr. Kidney Int. 65, 1703-1713, 2004.
  6. Kudo T, Kaneko M, Iwasaki H, Togayachi A, Nishihara S, Abe K, Narimatsu H. Normal Embryonic and Germ Cell Development in Mice Lacking alpha1,3-Fucosyltransferase IX (Fut9) Which Show Disappearance of Stage-Specific Embryonic Antigen 1. Mol Cell Biol. May 15;24(10):4221-4228, 2004.
  7. Cheng L, Tachibana K, Iwasaki H, Kameyama A, Zhang Y, Kubota T, Hiruma T, Tachibana K, Kudo T, Guo JM, Narimatsu H.Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15.FEBS Lett. May 21;566(1-3):17-24, 2004.
  8. Muto A, Tashiro S, Nakajima O, Hoshino H, Takahashi S, Sakoda E, Ikebe D, Yamamoto M, Igarashi K. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature. June 3 ; 429, 6691 566-571, 2004.
  9. Yamamoto T , Yoh K , Kobayashi A ,Ishi Y , Kure S , Koyama A , Sakamoto T , Sekizawa K, Motohashi H , Yamamoto M. Identification of polymorphisms in the promoter region of the human NRF2gene.Biochem Bipphys Res Commun. 321,72-79 , 2004.
  10. Nakano Y, Imagawa S, Mqatsumoto K, Stockmann C, Obara N, Suzuki N, Doi T, Kodama T, Takahashi S, Nagasawa T, Yamamoto M, Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity and restores indicators in an invivo mouse model of anemia of chronic disease. Blood. 104, 4300-4307, 2004.

  11. Shimizu R, Kuroha T, Ohneda O, Pan X, Ohneda K, Takahashi S, Philipsen S, Yamamoto M. Leukemogenesis caused by incapacitated GATA-1function. Mol. Cell. Biol. 24,10814-10825, 2004.